Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Biotech

Biotech

Group By Ticker
Sort By
Newest | Oldest
Read More
6 minute read
  • Biotech
  • General
  • Health Care
  • Media
  • News
  • Penny Stocks
  • Small Cap
  • Top Stories
  • Trading Ideas

Provention Bio’s Second Try, Apellis’s Eye Disorder Drug Review, 3 Adcom Verdicts And More: November’s Key PDUFA Catalysts Biotech Investors Must Know

By Shanthi Rexaline
November 1, 4:01 PM
Editor's note: This story has been corrected to reflect that the FDA deferred action on Amicus Therapeutics' Biologics License Application. 

APLS

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • News

Shockwave Confirms Consistent Outcomes For IVL In The Largest Prospective “Real World” Study Of Patients With Heavily Calcified Peripheral Arterial Disease

By Benzinga Newsdesk
November 1, 2:58 PM
 Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the final 1,373-patient cohort

SWAV

Read More
1 minute read
  • Biotech
  • General
  • News

‘Hillstream Biopharma Has Been Granted U.S. Patent Number 11,484,507 Titled “Polymeric Nanoparticles Providing Nucleic Acids Encoding Tnf-a (For Treating Certain Diseases Including Cancer)”‘ – USPTO

By Benzinga Newsdesk
November 1, 2:18 PM
Patent Public Search | USPTO  

HILS

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • News

FDA Says Teleflex Recalls Iso-Gard Filter S For Risk Of Splitting Or Detaching That May Cause Leakage And Insufficient Air Supply To Patients; FDA Says Has Identified Teleflex Recall Of Iso-Gard Filter S As A Class I Recall, Most Serious Type Of Recall

By Benzinga Newsdesk
November 1, 2:03 PM
- Reuters 

TFX

Read More
1 minute read
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • News

Horizon Therapeutics Does Not Have Meaningful Upside, Analyst Initiating Coverage Says

By Vandana Singh
November 1, 12:50 PM
HC Wainwright initiated coverage on Horizon Therapeutics plc (NASDAQ:HZNP) with a Neutral rating and a price target of $74. The analyst writes…

HZNP

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News
  • Small Cap

Anika Therapeutics Cingal Tops Steroid For Osteoarthritis Pain Relief

By Vandana Singh
November 1, 12:14 PM
Anika Therapeutics Inc (NASDAQ:ANIK) announced that Cingal met its primary endpoint in a Phase 3 Study (Cingal 19-01), demonstrating superiority over…

ANIK

Read More
2 minute read
  • Biotech
  • General
  • News

Applied BioMath Announces Collaboration With SpringWorks Therapeutics For Systems Pharmacology Modeling In Multiple Myeloma

By Benzinga Newsdesk
November 1, 11:09 AM
Applied BioMath (www.appliedbiomath.com), the industry-leader in providing model-informed drug discovery and development (MID3) support to help accelerate and de-risk therapeutic research and development (R&D), today

SWTX

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Movers
  • News
  • Trading Ideas

What’s Going On With BioCryst Pharmaceuticals Stock Today?

By Adam Eckert
November 1, 10:28 AM
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) shares are trading lower Tuesday after the company reported third-quarter financial results.

BCRX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Pfizer Touts Positive Data From Global Maternal Immunization Trial For Its Bivalent RSV Vaccine Candidate

By Vandana Singh
November 1, 10:13 AM
Pfizer Inc (NYSE:PFE) announced topline data from the Phase 3 MATISSE trial investigating its bivalent RSV prefusion vaccine candidate administered to…

PFE

Read More
1 minute read
  • FDA
  • General
  • Health Care
  • News

FDA Signals Shortage Of ICU Medical’s Tracheostomy Tubes

By Vandana Singh
November 1, 9:00 AM
The FDA said there was a shortage of tracheostomy tubes, including Bivona tracheostomy tubes manufactured by ICU Medical Inc (NASDAQ: ICUI). The agency…

ICUI

Posts pagination

Previous 1 … 641 642 643 … 795 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service